These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3765897)

  • 21. The European experience with use of clozapine.
    Naber D; Hippius H
    Hosp Community Psychiatry; 1990 Aug; 41(8):886-90. PubMed ID: 1976107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.
    Szymanski S; Lieberman J; Pollack S; Kane JM; Safferman A; Munne R; Umbricht D; Woerner M; Masiar S; Kronig M
    Biol Psychiatry; 1996 Feb; 39(4):249-54. PubMed ID: 8645771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New chemotherapy approaches to psychoses].
    Olié JP; Baylé FJ
    Encephale; 1997 Apr; 23 Spec No 2():2-9. PubMed ID: 9273302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clozapine and treatment of negative symptoms].
    Lançon C; Farisse J; Llorca PM
    Encephale; 1997 Sep; 23 Spec No 4():7-11. PubMed ID: 9417403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Some methodological considerations for the clinical evaluation of neuroleptics--comparative effects of clozapine and haloperidol on schizophrenics.
    Itoh H; Miura S; Yagi G; Sakurai S; Ohtsuka N
    Folia Psychiatr Neurol Jpn; 1977; 31(1):17-24. PubMed ID: 863344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroleptic treatment effect on mitochondrial electron transport chain: peripheral blood mononuclear cells analysis in psychotic patients.
    Casademont J; Garrabou G; Miró O; López S; Pons A; Bernardo M; Cardellach F
    J Clin Psychopharmacol; 2007 Jun; 27(3):284-8. PubMed ID: 17502776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple outcome assessment in a study of the cost-effectiveness of clozapine in the treatment of refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
    Rosenheck R; Cramer J; Xu W; Grabowski J; Douyon R; Thomas J; Henderson W; Charney D
    Health Serv Res; 1998 Dec; 33(5 Pt 1):1237-61. PubMed ID: 9865219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of clozapine on biogenic amines within the scope of drug treatment of schizophrenic psychoses in adolescence].
    Schulz E; Remschmidt H; Fleischhaker C
    Z Kinder Jugendpsychiatr; 1994 Dec; 22(4):285-98. PubMed ID: 7856324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Differential neuroleptic treatment of schizophrenic psychoses in puerperium: advantages of the atypical neuroleptic clozapine].
    Weller M; Kornhuber J
    Nervenarzt; 1992 Jul; 63(7):440-1. PubMed ID: 1501722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A two-year clinical and economic follow-up of patients on clozapine.
    Honigfeld G; Patin J
    Hosp Community Psychiatry; 1990 Aug; 41(8):882-5. PubMed ID: 2401478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Initial experience with clozapine in Woodbridge Hospital.
    Wong KE; Chong SA; Ngui F; Winslow M; Devan GS; Leong OK; Choo CH
    Singapore Med J; 1997 Aug; 38(8):336-8. PubMed ID: 9364887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Duration of a clozapine trial in neuroleptic-resistant schizophrenia.
    Meltzer HY
    Arch Gen Psychiatry; 1989 Jul; 46(7):672. PubMed ID: 2567591
    [No Abstract]   [Full Text] [Related]  

  • 33. Clozapine, chlorpromazine, and placebo in newly hospitalized, acutely schizophrenic patients: a controlled, double-blind comparison.
    Shopsin B; Klein H; Aaronsom M; Collora M
    Arch Gen Psychiatry; 1979 Jun; 36(6):657-64. PubMed ID: 375865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical experience with Leponex].
    Lange E; König L; Kühne GE; Liefke T
    Psychiatr Neurol Med Psychol (Leipz); 1975 Jun; 27(6):360-5. PubMed ID: 1208707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Results of the long term treatment with clozapine. Clinical and electroencephalographic study.
    Zapletálek M; Hanus H; Kucera V; Kuba M
    Act Nerv Super (Praha); 1989 Apr; 31(1):36-7. PubMed ID: 2571221
    [No Abstract]   [Full Text] [Related]  

  • 36. [EEG changes and seizures with clozapine medication in schizophrenic adolescents].
    Braun-Scharm H; Martinius J
    Z Kinder Jugendpsychiatr; 1991; 19(3):164-9. PubMed ID: 1962511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of clozapine: an antipsychotic for treatment-resistant schizophrenia.
    Stephens P
    Compr Psychiatry; 1990; 31(4):315-26. PubMed ID: 2201482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Severe late dyskinesia caused by neuroleptics in a young female. Follow-up and treatment].
    Diedrich U; Müller P
    Nervenarzt; 1989 Dec; 60(12):759-61. PubMed ID: 2514384
    [No Abstract]   [Full Text] [Related]  

  • 39. An investigation of clozapine in the treatment of acute and chronic schizophrenia and gross behaviour disorders.
    Hemphill RE; Pascoe FD; Zabow T
    S Afr Med J; 1975 Nov; 49(51):2121-5. PubMed ID: 1209429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Study of the strength, homogeneity and consistency of the neuroleptic clozapine in a group of hospitalized schizophrenics].
    Molcan J; Korínková V; Novotný V; Zucha I
    Cesk Psychiatr; 1988 Jun; 84(3):168-72. PubMed ID: 3409363
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.